Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
European Journal of Medicinal Chemistry|February 18, 2026
Tailoring cariprazine for dual disorders via secondary pharmacophore optimizationCaleb D Vogt, Julie Sanchez, Alessandro Bonifazi, et al.Ethnicity & Disease|August 5, 2003
Establishment of a binational cohort to study Helicobacter pylori infection in childrenKaren J Goodman, Kathleen O'Rourke, R Sue Day, et al.The Journal of Biological Chemistry|December 21, 2018
Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1Julie Sanchez, Zil E Huma, J Robert Lane, et al.Biochemical Pharmacology|November 8, 2024
Activated microglia secretome and proinflammatory cytokines increase neuronal mu-opioid receptor signalling and expressionJavier Cuitavi, Pere Duart-Abadia, Julie Sanchez, et al.Environmental Science & Technology|January 23, 2024
Predicting Anaerobic Membrane Bioreactor Performance Using Flow-Cytometry-Derived High and Low Nucleic Acid Content CellsHong Cheng, Julie Sanchez Medina, Jianqiang Zhou, et al.British Journal of Pharmacology|July 25, 2023
Assessment of the potential of novel and classical opioids to induce respiratory depression in miceRob Hill, Julie Sanchez, Laura Lemel, et al.Journal of Medicinal Chemistry|July 19, 2023
Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer AnalgesicsAlessandro Bonifazi, Elizabeth Saab, Julie Sanchez, et al.Elife|January 28, 2020
Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonismJ Robert Lane, Ara M Abramyan, Pramisha Adhikari, et al.Journal of Medicinal Chemistry|January 20, 2023
Dopamine D3/D2 Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective DisordersEmma S Gogarnoiu, Caleb D Vogt, Julie Sanchez, et al.Science Signaling|May 25, 2017
Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2Zil E Huma, Julie Sanchez, Herman D Lim, et al.Pageof 4